469 related articles for article (PubMed ID: 28938338)
1. Mortality implications of lower DBP with lower achieved systolic pressures in coronary artery disease: long-term mortality results from the INternational VErapamil-trandolapril STudy US cohort.
Wokhlu A; Smith SM; Gong Y; Handberg EM; Elgendy IY; Bavry AA; Cooper-DeHoff RM; Pepine CJ
J Hypertens; 2018 Feb; 36(2):419-427. PubMed ID: 28938338
[TBL] [Abstract][Full Text] [Related]
2. Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.
Bangalore S; Messerli FH; Franklin SS; Mancia G; Champion A; Pepine CJ
Eur Heart J; 2009 Jun; 30(11):1395-401. PubMed ID: 19351690
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Mortality in Hypertensive Patients With Coronary Artery Disease: Results From the US Cohort of the International Verapamil (SR)/Trandolapril Study.
Elgendy IY; Bavry AA; Gong Y; Handberg EM; Cooper-DeHoff RM; Pepine CJ
Hypertension; 2016 Nov; 68(5):1110-1114. PubMed ID: 27620390
[TBL] [Abstract][Full Text] [Related]
4. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
[TBL] [Abstract][Full Text] [Related]
5. Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.
Ruilope LM; Usan L; Segura J; Bakris GL
J Hypertens; 2004 Jan; 22(1):217-22. PubMed ID: 15106814
[TBL] [Abstract][Full Text] [Related]
6. The relationship of all-cause mortality to average on-treatment systolic blood pressure is significantly related to baseline systolic blood pressure: implications for interpretation of the Systolic Blood Pressure Intervention Trial study.
Okin PM; Kjeldsen SE; Devereux RB
J Hypertens; 2018 Apr; 36(4):916-923. PubMed ID: 29176391
[TBL] [Abstract][Full Text] [Related]
7. Association of 1-Year Blood Pressure Variability With Long-term Mortality Among Adults With Coronary Artery Disease: A Post Hoc Analysis of a Randomized Clinical Trial.
Dasa O; Smith SM; Howard G; Cooper-DeHoff RM; Gong Y; Handberg E; Pepine CJ
JAMA Netw Open; 2021 Apr; 4(4):e218418. PubMed ID: 33914047
[TBL] [Abstract][Full Text] [Related]
8. Mortality implications of angina and blood pressure in hypertensive patients with coronary artery disease: New data from extended follow-up of the International Verapamil/Trandolapril Study (INVEST).
Winchester DE; Cooper-Dehoff RM; Gong Y; Handberg EM; Pepine CJ;
Clin Cardiol; 2013 Aug; 36(8):442-7. PubMed ID: 23720247
[TBL] [Abstract][Full Text] [Related]
9. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
[TBL] [Abstract][Full Text] [Related]
10. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 13 - benefits and adverse events in older and younger patients with hypertension: overview, meta-analyses and meta-regression analyses of randomized trials.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2018 Aug; 36(8):1622-1636. PubMed ID: 29847485
[TBL] [Abstract][Full Text] [Related]
11. Risk and Blood Pressure Control Rates Across the Spectrum of Coronary Artery Disease in Hypertensive Women: An Analysis from The INternational VErapamil SR-Trandolapril STudy (INVEST).
Sava RI; Chen YE; Smith SM; Gong Y; Cooper-DeHoff RM; Keeley EC; Pepine CJ; Handberg EM
J Womens Health (Larchmt); 2020 Feb; 29(2):158-166. PubMed ID: 31403360
[No Abstract] [Full Text] [Related]
12. Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension.
Pepine CJ; Handberg-Thurmond E; Marks RG; Conlon M; Cooper-DeHoff R; Volkers P; Zellig P
J Am Coll Cardiol; 1998 Nov; 32(5):1228-37. PubMed ID: 9809930
[TBL] [Abstract][Full Text] [Related]
13. Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels--overview and meta-analyses of randomized trials.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2014 Dec; 32(12):2296-304. PubMed ID: 25259547
[TBL] [Abstract][Full Text] [Related]
14. Systolic blood pressure and subjective well-being in patients with coronary artery disease.
Gong Y; Handberg EM; Gerhard T; Cooper-Dehoff RM; Ried LD; Johnson JA; Pepine CJ;
Clin Cardiol; 2009 Nov; 32(11):627-32. PubMed ID: 19711440
[TBL] [Abstract][Full Text] [Related]
15. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?
Messerli FH; Mancia G; Conti CR; Hewkin AC; Kupfer S; Champion A; Kolloch R; Benetos A; Pepine CJ
Ann Intern Med; 2006 Jun; 144(12):884-93. PubMed ID: 16785477
[TBL] [Abstract][Full Text] [Related]
16. Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
Böhm M; Schumacher H; Teo KK; Lonn E; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder R; Weber M; Sliwa K; Williams B; Yusuf S
Eur Heart J; 2018 Sep; 39(33):3105-3114. PubMed ID: 29873709
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure targets for hypertension in people with diabetes mellitus.
Arguedas JA; Leiva V; Wright JM
Cochrane Database Syst Rev; 2013 Oct; (10):CD008277. PubMed ID: 24170669
[TBL] [Abstract][Full Text] [Related]
18. Is systolic blood pressure below 150 mm Hg an appropriate goal for primary prevention of cardiovascular events among elderly population?
Mohebi R; Mohebi A; Ghanbarian A; Momenan A; Azizi F; Hadaegh F
J Am Soc Hypertens; 2014 Jul; 8(7):491-7. PubMed ID: 25064771
[TBL] [Abstract][Full Text] [Related]
19. Effects of verapamil SR and atenolol on 24-hour blood pressure and heart rate in hypertension patients with coronary artery disease: an international verapamil SR-trandolapril ambulatory monitoring substudy.
Denardo SJ; Gong Y; Cooper-DeHoff RM; Farsang C; Keltai M; Szirmai L; Messerli FH; Bavry AA; Handberg EM; Mancia G; Pepine CJ
PLoS One; 2015; 10(4):e0122726. PubMed ID: 25835002
[TBL] [Abstract][Full Text] [Related]
20. Predictors of adverse outcome among patients with hypertension and coronary artery disease.
Pepine CJ; Kowey PR; Kupfer S; Kolloch RE; Benetos A; Mancia G; Coca A; Cooper-DeHoff RM; Handberg E; Gaxiola E; Sleight P; Conti CR; Hewkin AC; Tavazzi L;
J Am Coll Cardiol; 2006 Feb; 47(3):547-51. PubMed ID: 16458134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
